Scholarlink

<p>The emergence of ciprofloxacin-resistant <i>Salmonella</i> poses a significant challenge to antimicrobial therapy. Probiotics that inhibit ciprofloxacin-resistant Salmonella offer a safer alternative with fewer side effects than conventional antibiotics. In this study, a strain of <i>Companilactobacillus alimentarius</i> Y4, isolated from kimchi, exhibited strong antibacterial activity against <i>Salmonella</i> C1, <i>Escherichia coli</i>, and other intestinal pathogens. Biological characterization showed that <i>C. alimentarius</i> Y4 maintained a relative growth rate of 80% at pH 3.0 and 87.13% in the presence of 0.3% bile salts. It retained over 98.8% antibacterial activity even after exposure to pepsin, trypsin, protease K, and catalase. Additionally, <i>C. alimentarius</i> Y4 downregulated the pro-inflammatory cytokines interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α), while upregulating the anti-inflammatory cytokine IL-10, which may contribute to alleviating intestinal injury induced by ciprofloxacin-resistant <i>Salmonella</i> C1. Gut microbiota analysis revealed that <i>C. alimentarius</i> Y4 colonized the intestine and increased the abundance of beneficial gut microbes, including <i>Lachnospiraceae bacterium</i> COE1 and <i>Muribaculaceae bacterium</i> CAG-485. Metabolomic profiling further indicated that <i>C. alimentarius</i> Y4 upregulated metabolites such as L-leucine, L-lysine, and tryptophan, contributing to the restoration of intestinal metabolic balance. Collectively, <i>C. alimentarius</i> Y4 may mitigate intestinal inflammation by regulating cytokine expression, repairing mucosal damage, rebalancing gut microbiota composition, and restoring metabolic homeostasis. These findings indicate that <i>C. alimentarius</i> Y4 may contribute to alleviating intestinal inflammatory damage caused by multidrug-resistant Salmonella infection, suggesting its potential as a promising probiotic candidate.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Probiotic potential of Companilactobacillus alimentarius Y4 in alleviating ciprofloxacin-resistant Salmonella-induced intestinal inflammation through microbiota–metabolite modulation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月19日

查看全文
  • Tajin Wang,
  • Shuo Wang,
  • Tao Wan,
  • Qi Cui,
  • Lili Guan,
  • Chengguang He,
  • Jingrui Chen,
  • Lingcong Kong,
  • Haipeng Zhang,
  • Hongxia Ma

摘要

The emergence of ciprofloxacin-resistant Salmonella poses a significant challenge to antimicrobial therapy. Probiotics that inhibit ciprofloxacin-resistant Salmonella offer a safer alternative with fewer side effects than conventional antibiotics. In this study, a strain of Companilactobacillus alimentarius Y4, isolated from kimchi, exhibited strong antibacterial activity against Salmonella C1, Escherichia coli, and other intestinal pathogens. Biological characterization showed that C. alimentarius Y4 maintained a relative growth rate of 80% at pH 3.0 and 87.13% in the presence of 0.3% bile salts. It retained over 98.8% antibacterial activity even after exposure to pepsin, trypsin, protease K, and catalase. Additionally, C. alimentarius Y4 downregulated the pro-inflammatory cytokines interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α), while upregulating the anti-inflammatory cytokine IL-10, which may contribute to alleviating intestinal injury induced by ciprofloxacin-resistant Salmonella C1. Gut microbiota analysis revealed that C. alimentarius Y4 colonized the intestine and increased the abundance of beneficial gut microbes, including Lachnospiraceae bacterium COE1 and Muribaculaceae bacterium CAG-485. Metabolomic profiling further indicated that C. alimentarius Y4 upregulated metabolites such as L-leucine, L-lysine, and tryptophan, contributing to the restoration of intestinal metabolic balance. Collectively, C. alimentarius Y4 may mitigate intestinal inflammation by regulating cytokine expression, repairing mucosal damage, rebalancing gut microbiota composition, and restoring metabolic homeostasis. These findings indicate that C. alimentarius Y4 may contribute to alleviating intestinal inflammatory damage caused by multidrug-resistant Salmonella infection, suggesting its potential as a promising probiotic candidate.